Search research articles
Contact Us
Filters
Showing results (571-580 of 726) with videos related to
Page
of 73
Sort By:
Clinical Lymphoma
|
November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
C Visco, L J Medeiros, O M Mesina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
A Younes, H A Preti, F B Hagemeister, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics
Jay P McLaughlin, Ramanjaneyulu Rayala, Ashley J Bunnell, et al.
Breast Cancer Research and Treatment
|
August 8, 2019
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Jichao He, Ronan P McLaughlin, Vera van der Noord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease
F B Hagemeister, L M Fuller, W S Velasquez, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
Lisa L Wilson, Amy R Alleyne, Shainnel O Eans, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1989
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience
J A Spinolo, S Jagannath, K A Dicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
N L Berinstein, A J Grillo-López, C A White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Trimetrexate in relapsed T-cell lymphoma with skin involvement
A H Sarris, A Phan, M Duvic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Page
of 73
Search research articles
Search
Showing results (571-580 of 726) with videos related to
Sort By:
Page
of 73
Clinical Lymphoma
|
November 15, 2001
Non-Hodgkin's lymphoma affecting the testis: is it curable with doxorubicin-based therapy?
C Visco, L J Medeiros, O M Mesina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 28, 2001
Paclitaxel plus topotecan treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
A Younes, H A Preti, F B Hagemeister, et al.
International Journal of Molecular Sciences
|
September 9, 2022
Bis-Cyclic Guanidine Heterocyclic Peptidomimetics as Opioid Ligands with Mixed μ-, κ- and δ-Opioid Receptor Interactions: A Potential Approach to Novel Analgesics
Jay P McLaughlin, Ramanjaneyulu Rayala, Ashley J Bunnell, et al.
Breast Cancer Research and Treatment
|
August 8, 2019
Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer
Jichao He, Ronan P McLaughlin, Vera van der Noord, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's disease
F B Hagemeister, L M Fuller, W S Velasquez, et al.
Molecules (Basel, Switzerland)
|
June 10, 2022
Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain
Lisa L Wilson, Amy R Alleyne, Shainnel O Eans, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer
|
January 1, 1989
High-dose combination chemotherapy with cyclophosphamide, carmustine, etoposide, and autologous bone marrow transplantation in 60 patients with relapsed Hodgkin's disease: the M. D. Anderson experience
J A Spinolo, S Jagannath, K A Dicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 18, 1998
Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
N L Berinstein, A J Grillo-López, C A White, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2002
Trimetrexate in relapsed T-cell lymphoma with skin involvement
A H Sarris, A Phan, M Duvic, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 16, 2001
Clearing of cells bearing the bcl-2 [t(14;18)] translocation from blood and marrow of patients treated with rituximab alone or in combination with CHOP chemotherapy
M S Czuczman, A J Grillo-López, P McLaughlin, et al.
Page
of 73